Article

(2019) Design, Synthesis, Molecular Docking, and Cholinesterase Inhibitory Potential of Phthalimide-Dithiocarbamate Hybrids as New Agents for Treatment of Alzheimer's Disease. Chemistry & biodiversity. p. 13. ISSN 1612-1872

(2019) Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin-3-carboxamide-<i>N</i>-morpholine Hybrids as New Anti-Alzheimer Agents. Chemistry & biodiversity. p. 8. ISSN 1612-1872

(2019) Design, synthesis, and biological evaluation of novel 4-oxobenzo <i>d</i> 1,2,3-triazin-benzylpyridinum derivatives as potent anti-Alzheimer agents. Bioorganic & medicinal chemistry. pp. 2914-2922. ISSN 0968-0896

(2019) New benzyl pyridinium derivatives bearing 2,4-dioxochroman moiety as potent agents for treatment of Alzheimer's disease: Design, synthesis, biological evaluation, and docking study. Bioorganic Chemistry. pp. 506-515. ISSN 0045-2068

(2018) Novel cinnamic acid–tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study. Archiv der Pharmazie. ISSN 03656233 (ISSN)

(2015) Synthesis and Evaluation of Chroman-4-One Linked to <i>N</i>-Benzyl Pyridinium Derivatives as New Acetylcholinesterase Inhibitors. Archiv der Pharmazie. pp. 643-649. ISSN 0365-6233